You need to add option 3) 3) No sale because no ones interested .....unless sales in the UK take off and they generate independent confirmation of at least some of the Reduce It trial results Kiwi
For #1, I have to think Yes if it does get sold it makes sense that it is not a whole bunch after that date as exclusivity erodes every day, and why would BP wait until there is no exclusivity.
#2, $7.50 a share.
#3 for Kiwi - 50% chance that no one is interested. For #1 I said by that date if there is to be a sale, but there is also a chance no one wants to take a flyer on Amarin (Vascepa).